A series of pyrimidodiazepines was identified as potent Polo-like kinase 1 (PLK1) inhibitors. The synthesis and SAR are discussed. The lead compound 7 (RO3280) has potent inhibitory activity against PLK1, good selectivity against other kinases, and excellent in vitro cellular potency. It showed strong antitumor activity in xenograft mouse models.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2011.11.052 | DOI Listing |
Publication Analysis
Top Keywords
polo-like kinase
8
identification novel
4
novel potent
4
potent selective
4
selective inhibitors
4
inhibitors polo-like
4
kinase series
4
series pyrimidodiazepines
4
pyrimidodiazepines identified
4
identified potent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!